High affinity humanized anti-cea monoclonal antibodies

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 51/10 (2006.01) C07K 16/30 (2006.01) C07K 16/46 (2006.01) C12N 15/62 (2006.01) C12N 15/85 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2321947

Novel humanized monoclonal antibodies, fragments or derivatives thereof which specifically bind carcinoembryonic antigen (CEA) are provided as well as methods for their manufacture. These humanized antibodies are useful in the treatment of cancers which express CEA as well as for diagnostic purposes, e.g., for in vivo imaging of tumors or cancer cells which express CEA.

Cette invention concerne de nouveaux anticorps monoclonaux humanisés ainsi que des fragments ou des dérivés de ces anticorps, lesquels se lient de manière spécifique à l'antigène carcino-embryonnaire (ACE). Cette invention concerne également des procédés de production des ces anticorps et de leurs fragments ou dérivés. Ces anticorps humanisés sont utiles dans le traitement des cancers qui expriment l'ACE, ainsi qu'à des fins diagnostiques comme, par exemple, l'imagerie in vivo de tumeurs ou de cellules cancéreuses qui expriment l'ACE.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

High affinity humanized anti-cea monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with High affinity humanized anti-cea monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High affinity humanized anti-cea monoclonal antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1777146

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.